Keyphrases
Asymptomatic Carriers
92%
Unilateral Renal Agenesis
92%
RET mutation
92%
Thyroid Disorders
92%
Primary Aldosteronism
92%
Primary Hyperparathyroidism (pHPT)
92%
Unilateral Adrenalectomy
92%
Inferior Vena Cava Syndrome
92%
Renal Agenesis
46%
Hirschsprung Disease
46%
Extra-adrenal Pheochromocytoma
46%
Jelly
36%
Calcium Polysulfide
36%
C-cell Hyperplasia
30%
Follicular Adenoma
25%
Adenomatous Goiter
25%
Medullary Thyroid Carcinoma
23%
Left Adrenal Vein
23%
Dysgenesis
23%
Regional Lymph Node Dissection
23%
RET Gene
23%
Total Thyroidectomy
23%
Early Surgery
23%
Contralateral Kidney
23%
Compensatory Hypertrophy
23%
HER3
23%
Normal Renal Function
23%
Inferior Vena Cava Obstruction
23%
Stable Haemodynamics
23%
Retroperitoneal Hematoma
23%
Emergency Medical Care
23%
Protein Kinase A Activity
20%
Monoclonal Proliferation
20%
Corticoids
18%
Serum Potassium
18%
Aldosterone-producing Adenoma
18%
Anti-CD34 Antibody
16%
Medullary Carcinoma
16%
Benign Thyroid Tumor
16%
Contralateral Lesion
15%
Tumor Enlargement
15%
Partial Adrenalectomy
15%
Adrenocortical Function
15%
Addisonian Crisis
15%
Palmar-plantar Erythrodysesthesia
15%
RECIST 1.1
15%
Phase II Design
15%
Proliferation Marker
10%
Allred Score
10%
Score System
10%
Parathyroid Cells
10%
Medullary Tumor
8%
Adrenocortical Adenoma
8%
Tumor Cell Differentiation
8%
Follicular Tumor
8%
Hypoxia-inducible
8%
Differentiation State
8%
Cell Components
8%
Fascicular
8%
Tumor Syndrome
8%
Anaplastic Thyroid Cancer
8%
Proliferative Processes
8%
Complex Detection
8%
T3, T4
8%
Differentiated Carcinoma
8%
Thyroid Cancer Cells
8%
Slow Growth
8%
Human Thyroid
8%
Slow Progression
8%
Tissue Extracts
8%
Differentiated Cells
8%
Low-grade Malignancy
8%
PCR System
8%
TRAP Assay
8%
Taq DNA Polymerase
8%
Medicine and Dentistry
Anaplastic Thyroid Carcinoma
100%
Asymptomatic Carrier
92%
Multiple Endocrine Neoplasia Type 2a
92%
Lenvatinib
92%
Primary Hyperaldosteronism
92%
Solitary Kidney
92%
Primary Hyperparathyroidism
92%
Disease
61%
Renal Agenesis
46%
Hirschsprung's Disease
46%
Pheochromocytoma
46%
Calcitonin
46%
Polystyrenesulfonate Calcium
36%
Overall Survival
30%
Thyroidectomy
23%
Graves' Disease
23%
Thyroid Medullary Carcinoma
23%
Goiter
23%
Genetic Analysis
23%
Retroperitoneal Lymph Node Dissection
23%
Cell Hyperplasia
23%
Mineralocorticoid
18%
Hypoaldosteronism
18%
Survival Rate
15%
Adverse Event
15%
Progression Free Survival
15%
Monotherapy
15%
Systemic Therapy
15%
CD34 Antibody
15%
Hand Foot Syndrome
15%
Medullary Carcinoma
15%
Electrocorticography
15%
Malignant Neoplasm
15%
Loss of Appetite
15%
Parathyroid Cell
11%
Retroperitoneal Hematoma
11%
Inferior Cava Vein Obstruction
11%
Hypervascularity
7%
Tumor Angiogenesis
7%
Adrenal Cortex Function
6%
Pharmacology, Toxicology and Pharmaceutical Science
Anaplastic Thyroid Carcinoma
100%
Lenvatinib
92%
Solitary Kidney
92%
Multiple Endocrine Neoplasia Type 2a
92%
Thyroglobulin
92%
Disease
61%
Hirschsprung's Disease
46%
Kidney Agenesis
46%
Pheochromocytoma
46%
Overall Survival
30%
Goiter
23%
Thyroid Medullary Carcinoma
23%
Glial Cell Line Derived Neurotrophic Factor
23%
Medullary Carcinoma
15%
Survival Rate
15%
Lymphoma
15%
CD34 Antibody
15%
Follicular Carcinoma
15%
Loss of Appetite
15%
Adverse Event
15%
Monotherapy
15%
Syndrome
15%
Progression Free Survival
15%
Hand Foot Syndrome
15%
Malignant Neoplasm
15%
Tissue Extract
8%
Taq Polymerase
8%
Thyroid Follicular Carcinoma
7%
Papillary Carcinoma
7%